Cargando…

Epidemiology of Adult Soft-Tissue Sarcomas in Germany

We conducted a retrospective cohort study using data compiled from the regional German cancer registries by the Centre for Cancer Registry Data (ZfKD) at the Robert Koch Institut (RKI) to describe the epidemiology of adult soft-tissue sarcomas (STS) in Germany in 2003–2012, focusing on advanced STS....

Descripción completa

Detalles Bibliográficos
Autores principales: Saltus, Catherine W., Calingaert, Brian, Candrilli, Sean, Lorenzo, Maria, D'yachkova, Yulia, Otto, Thorsten, Wagner, Uwe, Kaye, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904765/
https://www.ncbi.nlm.nih.gov/pubmed/29849478
http://dx.doi.org/10.1155/2018/5671926
_version_ 1783315141441355776
author Saltus, Catherine W.
Calingaert, Brian
Candrilli, Sean
Lorenzo, Maria
D'yachkova, Yulia
Otto, Thorsten
Wagner, Uwe
Kaye, James A.
author_facet Saltus, Catherine W.
Calingaert, Brian
Candrilli, Sean
Lorenzo, Maria
D'yachkova, Yulia
Otto, Thorsten
Wagner, Uwe
Kaye, James A.
author_sort Saltus, Catherine W.
collection PubMed
description We conducted a retrospective cohort study using data compiled from the regional German cancer registries by the Centre for Cancer Registry Data (ZfKD) at the Robert Koch Institut (RKI) to describe the epidemiology of adult soft-tissue sarcomas (STS) in Germany in 2003–2012, focusing on advanced STS. We identified 33,803 incident adult cases of STS (other than the Kaposi sarcoma and gastrointestinal stromal tumors). The incidence of STS was 6.05 (95% confidence interval (CI), 5.82–6.29) per 100,000 in 2012 (4,079 cases). During 2003–2012, the most common histologic categories were leiomyosarcoma (19%), liposarcoma (16%), and STS not otherwise specified (14%). The overall STS-specific mortality rate in 2012 was 2.31 (95% CI, 2.06–2.57) per 100,000, and the median overall survival from initial diagnosis was 5.83 (95% CI, 5.50–6.08) years. Using STS mortality rates as a proxy for incidence of advanced STS in Germany and applying the age- and sex-specific rates to the corresponding German population, we estimated that 1,581 incident adult advanced STS cases occurred in Germany in 2012. Our findings contribute to a refined understanding of the population burden of STS in Germany, including the number of patients with advanced STS who may be candidates for systemic treatment.
format Online
Article
Text
id pubmed-5904765
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59047652018-05-30 Epidemiology of Adult Soft-Tissue Sarcomas in Germany Saltus, Catherine W. Calingaert, Brian Candrilli, Sean Lorenzo, Maria D'yachkova, Yulia Otto, Thorsten Wagner, Uwe Kaye, James A. Sarcoma Research Article We conducted a retrospective cohort study using data compiled from the regional German cancer registries by the Centre for Cancer Registry Data (ZfKD) at the Robert Koch Institut (RKI) to describe the epidemiology of adult soft-tissue sarcomas (STS) in Germany in 2003–2012, focusing on advanced STS. We identified 33,803 incident adult cases of STS (other than the Kaposi sarcoma and gastrointestinal stromal tumors). The incidence of STS was 6.05 (95% confidence interval (CI), 5.82–6.29) per 100,000 in 2012 (4,079 cases). During 2003–2012, the most common histologic categories were leiomyosarcoma (19%), liposarcoma (16%), and STS not otherwise specified (14%). The overall STS-specific mortality rate in 2012 was 2.31 (95% CI, 2.06–2.57) per 100,000, and the median overall survival from initial diagnosis was 5.83 (95% CI, 5.50–6.08) years. Using STS mortality rates as a proxy for incidence of advanced STS in Germany and applying the age- and sex-specific rates to the corresponding German population, we estimated that 1,581 incident adult advanced STS cases occurred in Germany in 2012. Our findings contribute to a refined understanding of the population burden of STS in Germany, including the number of patients with advanced STS who may be candidates for systemic treatment. Hindawi 2018-04-04 /pmc/articles/PMC5904765/ /pubmed/29849478 http://dx.doi.org/10.1155/2018/5671926 Text en Copyright © 2018 Catherine W. Saltus et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Saltus, Catherine W.
Calingaert, Brian
Candrilli, Sean
Lorenzo, Maria
D'yachkova, Yulia
Otto, Thorsten
Wagner, Uwe
Kaye, James A.
Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title_full Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title_fullStr Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title_full_unstemmed Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title_short Epidemiology of Adult Soft-Tissue Sarcomas in Germany
title_sort epidemiology of adult soft-tissue sarcomas in germany
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904765/
https://www.ncbi.nlm.nih.gov/pubmed/29849478
http://dx.doi.org/10.1155/2018/5671926
work_keys_str_mv AT saltuscatherinew epidemiologyofadultsofttissuesarcomasingermany
AT calingaertbrian epidemiologyofadultsofttissuesarcomasingermany
AT candrillisean epidemiologyofadultsofttissuesarcomasingermany
AT lorenzomaria epidemiologyofadultsofttissuesarcomasingermany
AT dyachkovayulia epidemiologyofadultsofttissuesarcomasingermany
AT ottothorsten epidemiologyofadultsofttissuesarcomasingermany
AT wagneruwe epidemiologyofadultsofttissuesarcomasingermany
AT kayejamesa epidemiologyofadultsofttissuesarcomasingermany